Evaluation of Predictive Data Mining Algorithms in Erythemato-Squamous
  Disease Diagnosis by Danjuma, Kwetishe & Osofisan, Adenike O.
  
Evaluation of Predictive Data Mining Algorithms in 
Erythemato-Squamous Disease Diagnosis. 
Kwetishe Danjuma1, Adenike Osofisan2 
 
 1 Department of Computer Science, Modibbo Adama University of Technology,  
Yola, Adamawa State, Nigeria 
 
2 Department of Computer Science, University of Ibadan, 
Ibadan, Oyo State, Nigeria 
 
 
Abstract 
A lot of time is spent searching for the most performing data 
mining algorithms applied in clinical diagnosis. The study set out 
to identify the most performing predictive data mining algorithms 
applied in the diagnosis of Erythemato-squamous diseases. The 
study used Naive Bayes, Multilayer Perceptron and J48 decision 
tree induction to build predictive data mining models on 366 
instances of Erythemato-squamous diseases datasets. Also, 10-fold 
cross-validation and sets of performance metrics were used to 
evaluate the baseline predictive performance of the classifiers. The 
comparative analysis shows that the Naive Bayes performed best 
with accuracy of 97.4%, Multilayer Perceptron came out second 
with accuracy of 96.6%, and J48 came out the worst with accuracy 
of 93.5%. The evaluation of these classifiers on clinical datasets, 
gave an insight into the predictive ability of different data mining 
algorithms applicable in clinical diagnosis especially in the 
diagnosis of Erythemato-squamous diseases. 
Keywords: Predictive Data Mining, Erythemato-squamous 
diseases, Naïve Bayes, Multilayer Perceptron, J48 decision tree, 
Waikato Environment for Knowledge Analysis.  
1. Introduction 
Predictive analytic is a branch of data mining concerned 
with the analysis of data to identify underlying trends, 
patterns, or relationships to predict future probabilities and 
trends [1]. It encompasses statistics, data mining and game 
theory that analyze current and historical facts to make 
predictions about future events of interest [2]. In predictive 
modelling, data is collected, a statistical model is 
formulated, predictions are made and the model is validated 
or revised as additional data becomes available [3]. Clinical 
data mining is based on strategic research to retrieve, 
analyze and interpret both qualitative and quantitative 
information available from medical datasets or records [4]. 
 
Predictive data mining automatically create classification 
model from training dataset, and apply such model to 
automatically predict other classes of unclassified datasets 
[5]. Predictive data mining deals with learning models to 
support clinicians in diagnostics, therapeutic, or monitoring 
tasks [6]. It learns from past experience and apply 
knowledge gained to future situations [7], by applying 
machines learning methods to build multivariate models 
from clinical data and subsequently make inferences on 
unknown data [8]. Machine learning model is related to the 
exploitation of supervised classification approaches. Prior to 
applying the learning model, the data is pre-processed to 
remove noise and ensure data mining principle is applied on 
real data [9]. Predictive data mining is the most common 
type of data mining that has the most application in business 
and real life, that is centered on data pre-processing, data 
mining and data post-processing collectively referred to as 
Knowledge Discovery in Databases [7]. Examples include 
the prediction of surgery outcome [10], breast cancer 
survival [11] and coronary heart disease risk [12] and [13] 
from variables such as age, sex, smoking and status, 
hypertension and various biomarkers. Erythemato-squamous 
disease (ESD) is a common skin disease in outpatient 
dermatology departments. The variants of ESD includes 
psoriasis, seboreic dermatitis, lichen planus, pityriasis rosea, 
chronic dermatitis and pityriasis rubra pilaris [14], [15], and 
[16]. In this paper, we set out to identify the most 
performing predictive data mining algorithms applied in the 
diagnosis of Erythemato-squamous skin disease.  
2. Literature Review 
2.1 Application of Predictive Data Mining in Clinical     
Diagnosis 
In disease diagnosis, [17] compared rule based Repeated 
Incremental Pruning to Produce Error Reduction (RIPPER), 
Decision Tree (DT), Artificial Neural Networks (ANN) and 
Support Vector Machine (SVM) on the basis of Sensitivity, 
Specificity, Accuracy, Error Rate, True Positive Rate and 
False Positive Rate, and 10-fold cross validation to measure 
the unbiased estimate of these prediction models. SVM 
model was adjudged the best classifier for Cardiovascular 
Disease (CVD) diagnosis. [18], compared DT, k-Nearest 
  
Neighbor (kNN), ANN, and classification based on 
clustering in the prediction of heart disease, and genetic 
algorithm (GA) to improve the predictive abilities of the 
chosen models. [19], demonstrated how to implement an 
evidence-based clinical expert system of a Bayesian model 
to detect coronary artery disease. The Bayesian was 
considered to have considerable advantage in dealing with 
several missing variables compared to logistics and linear 
regression models. In the diagnosis of Asthma with expert 
system, [20] did a comparative analysis of machine learning 
algorithms such as Auto-associative Memory Neural 
Networks (AMNN), Bayesian networks, ID3 and C4.5 and 
found AMNN to perform best in terms of algorithms 
efficiency and accuracy of disease diagnosis. In a study of 
Phospholipidosis, [21] used structure-activity relationships 
(SAR) to compare kNN, DT, SVM and artificial immune 
systems algorithms trained to identify drugs with 
Phospholipidosis potentials and SVM produced the best 
predictions followed by a Multilayer Perceptron artificial 
neural network, logistic regression, and kNN. In the 
diagnosis of Chronic Obstructive Pulmonary and 
Pneumonia diseases (COPPD), [22] compared neural 
networks and artificial immune systems. Also, [23] used 
DT, Naïve Bayes, and Neural Networks to analyzed heart 
disease. The neural network algorithm was found to predict 
heart disease with highest accuracy.  
2.2 Erythemato-Squamous Diseases (ESD) Diagnosis 
An Extreme learning machine and Artificial Neural 
Network was proposed by [24] to better identify the 
differential problem of Erythemato-Squamous skin diseases. 
A support vector machine (SVM) based on random 
subspace (RS) and feature selection was used to solve 
differential problem of Erythemato-Squamous diseases [25]. 
A Catfish Binary Particle Swarm Optimization 
(CatfishBPSO), Kernelized Support Vector Machines 
(KSVM), and Association Rule feature selection method 
was used to diagnose Erythemato-squamous diseases [26]. 
The AR-CatfishBPSO-KSVM model gained baseline 
performance accuracy of 99.09% compared to Support 
vector machines and association rules - multilayer 
perceptron (AR-MLP). A new model based on Adaptive 
Neuro-Fuzzy Inference System (ANFIS) was used in the 
detection of Erythemato-squamous diseases [16]. They 
claim ANFIS has some potentials in detecting the 
Erythemato-squamous diseases. Another diagnosis model 
based on Support Vector Machine (SVM) with a novel 
hybrid feature selection method - Improved F-score and 
Sequential Forward (IFSFFS) was used on five random 
training-test partitions of the Erythemato-squamous diseases 
datasets from University of California Irvine (UCI) machine 
learning repository database [27]. The result shows that 
SVM-based model with IFSFFS achieved the optimal 
classification accuracy. [28], used Rough-Neuro hybrid 
method to achieve accurate Erythemato-squamous diseases 
diagnosis. The method incorporates Rough sets Johnson 
Reducer for reduction of relevant attributes and artificial 
neural network Levenberg-Marquardt algorithm for the 
classification of the diseases. The model was claimed to 
have diagnose the diseases at an accuracy of 98.8%. Two-
stage hybrid feature selection algorithms for diagnosing 
Erythemato-squamous diseases. It incorporate Support 
Vector Machines (SVM) as a classification tool, and the 
extended Sequential Forward Search (SFS), Sequential 
Forward Floating Search (SFFS), and Sequential Backward 
Floating Search (SBFS), as search strategies, and the 
generalized F-score (GF) to evaluate the importance of each 
feature. The two-stage hybrid model was claimed to have 
achieved better classification accuracy when compared to 
available algorithms for Erythemato-squamous diseases 
[29]. 
 
3. Predictive Data Mining (PDM) Algorithms 
to Compare 
3.1 Decision Tree (DT) Algorithm 
Decision tree is a predictive data mining techniques often 
used in clinical medicine to easily visualize, and understand 
resistant to noise in data. And is applicable in both 
regression and association data mining tasks [30] capable of 
handling continuous attributes, which are essential in case of 
medical data e.g. blood pressure, temperature, etc. It is a 
non-parametric supervised learning method used for 
classification to create models that predicts the value of a 
target variable by learning simple decision rules inferred 
from the data features [31]. Decision trees are significantly 
faster than neural networks with a shorter learning curve 
that is mainly used in the classification and prediction to 
represent knowledge. The instances are classified by sorting 
them down the tree from the root node to some leaf node. 
The nodes are branched based on if-then condition [32]. 
The variants of decision tree algorithm includes CART, 
ID3, C4.5, SLIQ, and SPRINT [33]. C4.5 algorithms is an 
extension of ID3 algorithms that uses concept of divide-and-
conquer to construct a tree from a training set S  [34], and 
each path in the decision tree can be regarded as a decision 
rule [35]. The decision tree is built of nodes which specify 
conditional attributes – symptoms  isssS ,...,, 21 , 
branches which show the values of kiv ,  i.e. the thh   
range for thi   symptom and leaves which present 
decisions  kdddD ,...,, 21   and their binary values, 
  
 1,0dkw . A sample decision tree is presented in Fig.1, 
and as a set of association rules in equation (1). 
      1,, 11,221,11  dvSvS  
     0,, 12,221,11  dvSvS  
     1,, 21,332,11  dvSvS  
     0,, 22,332,11  dvSvS  
   1, 33,11  dvS  
 
 
 
 
 
(1) 
 
 
Fig. 1 Sample decision tree applicable in clinical medicine 
3.2 Artificial neural networks (ANN’s) Algorithm 
The main function of Artificial Neural Networks is 
prediction. Despite its complexity and difficulty in 
understanding the predictions, it has been successfully 
applied in clinical medicine especially in prediction of 
coronary artery disease, EEG signals processing and the 
development of novel antidepressants [30]. ANN is 
biologically inspired, highly sophisticated analytical 
techniques, capable of modelling extremely complex non-
linear functions [36], that are modelled based on the 
cognitive learning process and the neurological functions of 
the human brain, consisting of millions of neurons 
interconnected by synapses [37], and capable of predicting 
new observations after learning from existing data. Neural 
networks are also capable to predict changes and events in 
the system after the process of learning [32]. The 
interconnected sets of neurons are divided into three: input, 
hidden, and output ones. In clinical medicine, the patient’s 
symptoms could serve as input set S , and disease could 
serve as output set D  to the neural network. The hidden 
neuron processes the outcome of preceding layers. The 
attributes that are passed as input to the network form the 
first layer, and the direction of the network symbolizes the 
dataflow during the process of prediction. The process of 
learning in ANN is to solve a task T , having a set of 
observations and a class of functions F , which is to find 
 as the optimal solution to the task [30]. The most 
popular of the ANN being Multilayer Perceptron algorithm. 
MLP is most suitable for approximating a classification 
function, and consists of a set of sensory elements that make 
up the input layer, one or more hidden layers of processing 
elements, and the output layer of the processing elements 
[34]. The Multi-Layer Perceptron (MLP) with back-
propagation (a supervised learning algorithm) is arguably 
the most commonly used and well-studied ANN architecture 
capable of learning arbitrarily complex nonlinear functions 
to arbitrary accuracy levels [17]. It is essentially the 
collection of nonlinear neurons (perceptron’s) organized 
and connected to each other in a feed forward multi-layer 
structure as shown in Fig [38], defines ANN based on: a) 
Interconnection pattern between different layers of neurons; 
b) Learning process for updating the weights of the 
interconnection; and c) Activation function that converts a 
neuron’s weighted input to its output activation. 
 
Fig. 2 Graphical depiction of ANN for clinical diagnosis for symptoms 
( 4321 ,,, SSSS ) like age, blood pressure, etc. and diagnosis 
( 21,dd ) 
3.3 Naïve Bayes Algorithm 
Naïve Bayes is a Bayesian Network based on Bayes rules of 
simple conditional probability that estimate the likelihood of 
a property given the set of input data. Naïve Bayes require 
small amount of training data to estimate parameters such as 
mean and variance necessary for classification [39]. The 
structure of a Naïve Bayes model forms a Bayesian network 
of nodes with one node for each attribute. The nodes are 
  
interconnected with directed edges and form a directed 
acyclic graph [30] Bayesian networks uses directed acyclic 
graphs to model the dependencies among variables [40]. 
Each node in the acyclic directed graph represents a 
stochastic variable and arcs represent a probabilistic 
dependency between a node and its parents [35]. The 
Bayesian Network is a way of representing probabilistic 
relationships between variables associated with an outcome 
of interest. The outcome of interest could be uncertainty 
essential during clinical diagnosis, prediction of patient’s 
prognosis and treatment selection. The probabilities applied 
in the Naïve Bayes algorithm are calculated according to the 
Bayes’ Rule. The probability of the likelihood of some 
conclusion S , given some evidence or observation T, where 
  a dependence relationship between S and T , denoted 
as )|( TSP , can be calculated based on Eq. 1;   
 
 
)(
)()|(
|
TP
SPSTP
TSP

  
(1) 
This conditional relationship allows an investigator to gain 
probability information about either S  or T with the 
known outcome of the other [41].  
 
4. Predictive Model Performance Evaluation 
Metrics 
Evaluation of predictive data mining algorithms can be 
compared according to a number of measures. In comparing 
the performance of different predictive data mining 
algorithms to determine its predictability, some quantities 
that interpret the goodness of fit of a model, and error 
measurements must be considered [7]. Though empirical 
studies claimed that it is difficult to decide which metric to 
use for different problem, each of them has specific features 
that measures various aspects of the algorithms being 
evaluated. It is often difficult to state which metrics is the 
most suitable to evaluate algorithms in clinical medicine due 
to large weighted discrepancies that often arise between 
predicted and actual value or otherwise. For instance, some 
metrics such as true positive rate (TPR) take higher values if 
the algorithm gives better results compared to metric such 
as errors that takes lower values [30].  
 
4.1 Accuracy, Sensitivity & Specificity (ASS) 
ASS are statistical measures commonly used to explain 
clinical diagnostic test, and to estimate how good and 
consistent was the diagnostic test [42]. In clinical medicine, 
the ability to detect patients with sickness or exclude 
patients without sickness is often described by terms such as 
sensitivity, specificity, positive predictive value and 
negative predictive value. The True Positive Rate, False 
Positive Rate, True Negative Rate and False Negative Rate 
determines the predictive data mining efficiency [43]. The 
sensitivity metrics is also called true positive rate or positive 
class accuracy, while specificity is referred to as true 
negative rate or negative class accuracy [44]. In this study, 
we used three predictive model performance evaluation 
metrics; accuracy (Eq. (2)), sensitivity (Eq. (3)), and 
Specificity (Eq. (4)). 
a. Accuracy-compares how close a new test value is 
to a value predicted by if ... then rules [45], written 
as in Eq.2; 
 
Accuracy %100
FNFPTNTP
TNTP


  
(2) 
b. Sensitivity-measures the ability of a test to be 
positive when the condition is actually present. It is 
often recognize as false-negative rate, recall, Type 
II error, β error, error of omission, or alternative 
hypothesis [45], written as in Eq.3; 
 
Sensitivity %100
FNTP
TP

  
(3) 
c. Specificity-measures the ability of a test to be 
negative when the condition is actually not present. 
It is often recognize as false-positive rate, 
precision, Type I error, α error, error of 
commission, or null hypothesis [45], written as in 
Eq.4; 
 
Specificity %100
FPTN
TN

  
(4) 
d. Predictive Accuracy (PA)-gives an overall 
evaluation. It is also known as the percentage 
proportion of correctly classified cases to all cases 
in the set. The larger the predictive accuracy the 
better the situation. The predictive accuracy is 
written as in Eq.5 
 
       PA %100
FNFPTNTP
TNTP


  
 
         
(5) 
 
4.2 n Fold cross-validation 
The n Fold cross-validation or rotation estimation is a 
model used to estimate how accurately a model will perform 
in practice. It involves splitting at random a sample data 
R into complimentary f mutually exclusive subsets (the 
  
folds: fRRR ,...,, 21 ) for approximately equal size [11]. In 
order to reduce variability, the classification model is 
trained and tested f times. Each time   ft ,...,2,1 , it is 
trained on all but one-fold )(Rt known as training set, and 
tested on the remaining single fold )(Rt , known as 
validation or testing set. The cross-validation estimate of the 
overall accuracy is the average of the n  individual accuracy 
measures represented by Eq.6 
 



f
i
Ai
f
CA
1
1
 
(6) 
Where CA stands for Cross-Validation accuracy, f is the 
number of folds used, and A is the accuracy measure of 
each fold [11] and [46]. Since the cross-validation accuracy 
depends on the random assignment of the individual cases 
into n  distinct folds, it is often stratified by creating folds 
that contain approximately the same proportion of predictor 
labels as the original dataset to generate results with lower 
bias and variance as compared to regular -fold cross-
validation [47]. 
4.3 Receiver Operating Characteristics (ROC) 
ROC is the ratio of FP  and TP  rate (axis y). It plots the 
curve with x axis representing FP rate and y axis 
representing the TP rate. The ROC curve has been 
recommended as an appropriate measure of diagnostic 
accuracy by clinical epidemiologists [30]. ROC curve 
(AUC) is a metric of algorithms’ performance. The larger 
the area under the curve (AUC), the better the model.  
 
4.4 Recall, precision and -F Measure 
The recall, precision and F-measure are additional 
parameters that could help physician determine exactly 
whether a patient is ill or not. Recall is the same in 
application as sensitivity, F-measure is the harmonic mean 
of both recall and precision, while specificity is the reverse 
of sensitivity presented by Eq.7, Eq.8 and Eq.9;  
 
Precision
FPTP
TP

  
(7) 
 
Recall
FNTP
TP

  
(8) 
 
F-measure
recallprecision
recallprecision


**2
 
(9) 
Other performance metrics used in this study are presented 
in Eq.10, Eq.11, Eq.12 and Eq.13; 
a. Mean absolute error  
 
n
apap nn ||...|| 11 
 
(10) 
b. Root mean square error 
 
 
n
apap nn
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(11) 
 
c. Relative absolute error 
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(12) 
 
d. Root relative squared error 
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(13) 
 
Where 
i
ai
n
a
1
, 
p
represents predicted target 
values: n
ppp ,...,, 21  and a  represents actual 
value: n
aaa ,...,, 21  
 
5. Empirical Results and Analysis  
5.1 Erythemato-Squamous Diseases Data Analysis 
In this study, we used ESD dataset from the UCI machine 
learning repository database. The data contains 366 number 
of instances, and 34 attributes. Patients were first evaluated 
clinically with 12 features. Afterwards, skin samples were 
taken for the evaluation of 22 histopathological features. 
The values of the histopathological features are determined 
by an analysis of the samples under a microscope. The 
family history feature with value 1 means any of these 
features has been observed in the family and 0 otherwise. 
The age feature is the patient age. Every other clinical or 
histopathological feature was assigned a value in the range 
of 0 - 3. Where, 0 means the absence of the feature, 3 means 
the largest amount possible, and 1, 2 means the relative 
intermediate values [29]. All attributes takes 3 values except 
the diagnosis attributes that take values in the range of 1-6, 
and the family-history attribute is binomial. Only the age 
  
attribute is continuous attributes with 8 missing 
distinguished with ‘?’. We removed the missing values in 
the age attribute because in clinical medicine, it is difficult 
to specify a likely range of values to replace missing values 
without being biased [30]. The details of the dataset is 
presented in Table 1.  
Table 1 Erythemato-squamous diseases dataset from UCI Repository 
 
Classes of Diagnosis  
Features (F) & Values 
Clinical  Histopathological  
:1C psoriasis :1f erythema :12f melanin incontinence 
:2C seboreic dermatitis :2f scaling :13f eosinophils in the infiltrate 
:3C lichen planus :3f definite borders :14f PNL infiltrate 
:4C pityriasis rosea :4f itching :15f fibrosis of the papillary dermis 
:5C chronic dermatitis :5f koebner phenomenon :16f exocytosis 
:6C pityriasis rubra pilaris :6f polygonal papules :17f acanthosis 
 :7f follicular papules :18f hyperkeratosis 
 :8f oral mucosal involvement :19f parakeratosis 
 :9f knee and elbow involvement :20f clubbing of the rete ridges 
 :10f scalp involvement :21f elongation of the rete ridges 
 :11f family history (0 = no,1= yes) :22f thinning of the suprapapillary epidermis 
 :34f age (linear)  :23f spongiform pustule 
  :24f munro microabcess 
  :25f focal hypergranulosis 
  :26f disappearance of the granular layer 
  :27f vacuolisation and damage of basal layer 
  :28f spongiosis 
  :29f saw-tooth appearance of retes 
  :30f follicular horn plug 
  :31f perifollicular parakeratosis 
  :31f inflammatory monoluclear infiltrate 
  :33f band-like infiltrate 
number of Instances 366 
number of Attributes 34 
Missing attributes values (in age attribute) distinguished with ? 8 
 
 
 
 
 
 
  
 
 
Table 2 Performance Evaluation Comparisons with respect to 10-fold Cross-validation 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3 10-fold Stratified cross-validation performance comparison for ESD 
Datasets Performance Metrics Naïve Bayes Multilayer Perceptron J48 
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Correctly Classified Instances 
97.4 96.6 93.5 
Mean absolute error                       
1.0 1.3 2.9 
Root mean squared error 
7.4 9.7 13.9 
Relative absolute error 
4.0 5.2 10.6 
Root relative squared error 
20.4 26.7 38.2 
True Positive (TP) Rate 
97.5 96.6 93.6 
False Positive (FP) Rate 
0.4 0.7 1.9 
Precision 
97.6 96.7 93.6 
Recall 
97.5 96.6 93.6 
F-Measure 
97.5 96.7 93.5 
ROC Area (AUC) 
99.9 99.8 96.6 
  
6. Results and Discussion 
We used Waikato Environment for Knowledge Analysis 
(WEKA) to simulate the baseline performance accuracy of 
the classifiers in a more convenient manner [48], to 
determine which scheme is statistically better than the 
others. We used stratified 10-fold cross-validation 
evaluation model in the final analysis. Stratified 10-fold 
cross-validation (k = 10) is the most common [49], and 
universal [50] evaluation models, with lower sample 
distribution variance compared to the hold-out cross-
validation. In the final comparative analysis, the results 
shows that J48 classifier achieved classification accuracy of 
93.5%, with a True Positive rate of 93.6% and a ROC Area 
(AUC) of 96.6%. The Multilayer Perceptron classifier 
achieved a classification accuracy and True Positive rate of 
96.6%, and a ROC Area (AUC) of 99.8%. However, the 
Naive Bayes was found to have performed better J48 and 
Multilayer Perceptron classifiers. The Naïve Bayes 
achieved a classification accuracy of 97.4% with a True 
Positive rate of 97.5%, and a ROC Area (AUC) of 99.9%. 
Table 2 and Fig. 3 presents the complete comparative 
analysis in both tabular and graph format for better 
visualization and analysis.  
 
7. Conclusions 
In this paper, we set out to identify the most performing 
predictive data mining algorithms applied in the diagnosis 
of Erythemato-squamous disease (ESD). The ESD dataset 
was obtained from the University of California Irvine (UCI) 
machine learning repository database. We pre-processed the 
data to remove noise and smoothen the sample distribution 
to avoid bias analysis. We removed the missing values in 
the age attributes because it was difficult to specify the 
likely range of values to replace the missing values 
distinguished with ‘?’, in Table  without bias [30]. In this 
study, the family history attribute with value 1 means the 
symptom or feature is observed in the family and 0 
otherwise. In other histopathological features, 0 means the 
absence of symptoms, 3 means the largest amount possible, 
and 1,2 means the relative intermediate values observed 
[29].  
 
We used the Naive Bayes, Multilayer Perceptron and J48 
decision tree predictive data mining algorithm to determine 
the ESD diseases. The three classifiers were calibrated to 
establish optimal parameter settings that maximizes the 
baseline performance accuracy of each classifier. Also, 
stratified 10-fold cross-validation evaluation model was 
used to measure the unbiased predictive accuracy of the 
three algorithms. We used 9 of 10 folds for training and the 
10th fold for testing to ensure we obtained a less biased 
baseline performance accuracy measures to compare the 
three classifiers. The final comparative analysis of the 
models shows that the Naive Bayes classifier performed 
best with a classification accuracy of 97.4% with a True 
Positive rate of 97.5% and a ROC Area (AUC) of 99.9%. 
The Multilayer Perceptron classifier came out to be second 
best with a classification accuracy and True Positive rate of 
96.6%, and a ROC Area (AUC) of 99.8%. And the J48 
decision tree classifier came out to be the worst with 
classification accuracy of 93.5%, with a True Positive rate 
of 93.6% and a ROC Area (AUC) of 96.6%. In our future 
research, we hope to investigate the predictive abilities of 
Naive Bayes, Multilayer Perceptron and J48 decision tree 
induction in clinical prognosis. Sometimes clinical data are 
noisy and imbalanced. The right sampling techniques and 
the most appropriate evaluations metrics should be used to 
evaluate the performance of the classifiers, and subject such 
result to rigorous assessment before applying it to real-life 
clinical decision. 
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